USPTO 2015–2025 USPTO PatentsView US Corporation

PerkinElmer Health Sciences, Inc.

USPTO PatentsView assignee record - 185 granted patents across 55 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Perkinelmer ranks #2,132 of 49,997 tracked US assignees by granted-patent volume, with 185 patents across 55 technology areas.

#2,132
of 49,997 US assignees by volume
Top 6%
by Innovation Score (56.6/100)
19.7
avg claims per patent
-46%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2132 · US Corporation #2,132 · 185 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 185 grants
  • TOP-DECILE #2,132/49,997
  • PHOTO-FINISH National Taiwan…
  • CPC-WIDE G01N · 55 areas
  • INNOV-PAR 56.6/100
  • CLAIMS-RICH 19.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -46% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Taiwan University of Science and Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Perkinelmer

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Perkinelmer's Innovation Score is 56.6/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Perkinelmer's grant cadence moved

Between 2020–2024, PerkinElmer Health Sciences, Inc. received 65 grants versus 120 in 2015–2019 (-46% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 28 grants and bottomed in 2024 at 1. Lead class G01N accounts for 44.9% of the portfolio across 55 subclasses. Volume neighbours: National Taiwan University of Science and Technology (#2,130) and Adtran, Inc. (#2,138).

Perkinelmer's three-year grant acceleration

From 2019–2021 to 2022–2024, PerkinElmer Health Sciences, Inc. moved from 71 to 19 grants (0.27x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,029. See the growth leaderboard.

Who files at PerkinElmer's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows PerkinElmer holds 185 patents at rank #2,134, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near PerkinElmer

By rank, the assignees closest to #2,134 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in PerkinElmer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for PerkinElmer, neither rank-band nor same-CPC leaders (those blocks stay above).

Perkinelmer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0102030 2015201620172018201920202021202220232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
PerkinElmer Health Sciences, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 21 11.4%
2016 28 15.1%
2017 28 15.1%
2018 18 9.7%
2019 25 13.5%
2020 22 11.9%
2021 24 13.0%
2022 13 7.0%
2023 5 2.7%
2024 1 0.5%

Which technologies does PerkinElmer Health Sciences, Inc. patent most?

Top 15 of 55 technology areas

Where it ranks

Overall rank by patents

#2,132

of 49,997 tracked assignees

Innovation Score

56.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

PerkinElmer Health Sciences, Inc.'s patent record in context - here's where to go next.

  • PerkinElmer Health Sciences, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 44.9% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #2,132 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare PerkinElmer Health Sciences, Inc. against National Taiwan University of Science and Technology, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 56.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.